Edition: Global

Email: Passwd: or sign up now for free news alerts, archives

One News Page

71.2°F  •  Ashburn, VA  •  [Local News]

"Pancreatic Cancer Drug" News

|<  Page 1  >>

	Why Clovis Oncology Shares More Than Doubled Filed under: Investing Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing.. DailyFinance 2 weeks ago New Pancreatic Cancer Drug an FDA Priority Filed under: Investing The FDA has granted *Celgene*'s abraxane priority review as a first-line treatment for advanced pancreatic cancer, a move that shortens the normal review period by four.. DailyFinance 3 weeks agoAlso reported by •Motley Fool Tackling Cancer: Pancreatic Cancer's Biggest Current & Upcoming Players Filed under: Investing As I noted 12 weeks ago, cancer statistics are both staggering and disappointing. Although cancer deaths per 100,000 people have been on the downswing since 1991 thanks to.. DailyFinance 3 weeks ago 3 Humongous Health-Care Stocks This Week Filed under: Investing Up, up, and away. That's the motto for the market as a whole so far this year, but it's also especially applicable for a select group of stocks. Here are three humongous.. DailyFinance on May 18, 2013 Peregrine Pharmaceuticals Earnings: An Early Look Filed under: Investing Earnings season is winding down, with most companies already having reported their quarterly results. But there are still some companies left to report, and *Peregrine.. DailyFinance on March 9, 2013 Silence Therapeutics gets German approval for cancer drug trial (Reuters) - Biotech research and development company Silence Therapeutics said it received approval from German authorities for trials of its pancreatic cancer drug and was reviewing financing options.. Reuters on March 5, 2013Also reported by •Reuters India Threshold Pharmaceuticals (THLD) +6.3% premarket after earning a $30M milestone payment from drug partner Merck (MRK), which started a late-stage study of THLD's pancreatic cancer drug. TH-302 is an investigational hypoxia-targeted drug designed to be act SeekingAlpha on January 25, 2013 Pancreatic Cancer Drug Found to Extend Life Celgene’s drug Abraxane prolonged the lives of patients with advanced pancreatic cancer by almost two months in a clinical trial, but the gains were not as big as expected. NYTimes.com on January 22, 2013  |<  Page 1  >>
Our Facebook Page LIKE us now: Current Topics Michael Hastings Katy Perry Chrysler Agrees To Recall Miss Utah G8 Summit Facebook Local News Ashburn area Staff Stories Brazil nationwide protest erupts into violence and chaos New Samsung Galaxy S4 to double 4G speed Need fresh drinking water for half a million people? Tow an iceberg! One dead and more than 30 injured in chemical plant explosion Portrait of the Queen defaced with spray paint at Westminster Abbey

Environmentally friendly: One News Page is hosted on servers powered solely by renewable energy

© 2013 One News Page Ltd. All Rights Reserved.  |  About us  |  Press Room  |  Terms & Conditions  |  Privacy Policy  |  Content Accreditation  RSS  |  News for my Website  |  Free news search widget  |  Advertise  |  Help  |  Contact us  |  DMCA / Content Removal How are we doing? Send us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter   FIND us on Google+  Switch to U.S. version